Various alphabetized medical records
Industries

Life Sciences Antitrust & Competition

CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.

Engagements

  • 01
    CRA Calculates State Medicaid Damages for Anticompetitive Harm
    On behalf of a party to a reverse payment settlement, CRA’s life sciences consultants were asked to calculate damages to a state Medicaid program. The CRA...
    View engagement
  • 02
    FTC reverses Administrative Law Judge on Illumina/Grail
    On April 3, the Federal Trade Commission (FTC) reversed the decision of an Administrative Law Judge by finding that Illumina’s $7.1 billion acquisition of...
    View engagement
  • 03
    CRA consultant opines on market definition in pharmaceuticals dispute involving antidepressants
    CRA consultants analyzed market power and alleged anticompetitive conduct for a CNS therapy. In defining the relevant antitrust market, our work accounted for...
    View engagement

Contact a Life Sciences Antitrust & Competition expert.

See all Life Sciences Antitrust & Competition experts.

Subscribe to receive our latest Insights.

Subscribe